News
Shares of Evoke Pharma are trading sharply higher Wednesday morning. The specialty pharma company received a U.S. Patent Office Notice of Allowance for a new patent on its lead product, GIMOTI.
Fierce Pharma Asia—GSK's massive Hengrui deal; Takeda's revenue drop; Celltrion's major US plant buy
GSK signed a 12-asset licensing deal with Hengrui Pharma. Generic erosion on Vyvanse continued to hurt Takeda. Celltrion is ...
The new franchise locations include Pasadena, California, owned by Saul Machado; Livermore, California, owned by Ray Ocon; ...
Madrigal Pharmaceuticals ( NASDAQ: MDGL) said it has signed a global licensing deal with CSPC Pharmaceutical for SYH2086, a ...
From jerseys that stood the test of time to duds that teams couldn't ditch soon enough, here's the best and worst for every team.
9h
Axios on MSNMore pharma giants embrace direct-to-consumer sales
Drugmakers are increasingly using telehealth platforms to sell their medicines directly to patients — and President Trump is ...
At a time when AI is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an interview why empathy, context, and ethics still require a human touch.
An epic fantasy world doesn't just spring to life overnight. From Bag End to Eregion, here's an in-depth look behind the scenes of the entire "Lord of the Rings" franchise. Forth Eorlingas!
Does Verona Pharma PLC American Depositary Share (VRNA) have what it takes to be a top stock pick for momentum investors? Let's find out.
For years, the franchise has lacked a real sense of identity or culture — but that might finally be changing. Sure, it’s not the NBA roster just yet — but what’s happening in Summer League ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results